Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.
about
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancerSystemic therapies for pancreatic cancer--the role of pharmacogeneticsThymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.Thymidylate synthase and thymidine phosphorylase mRNA expression in primary lesions using laser capture microdissection is useful for prediction of the efficacy of FOLFOX treatment in colorectal cancer patients with liver metastasis.Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer.Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer53BP1 sensitizes breast cancer cells to 5-fluorouracilThymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.Pre-operative radiochemotherapy of locally advanced rectal cancerCapecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trialPhase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinomaMitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers.
P2860
Q24651163-42D60D94-E288-4890-BB2B-BE485041BC69Q27021716-467AF05F-22BE-4A23-BF12-9749EC19B705Q33395508-63760E3C-46B8-4BD0-8E02-58F1D342A98AQ34333072-2F7F1DEF-8607-4D48-881E-37BD614682FDQ34414547-1ADCCE94-0243-4DA7-9791-2B275D5843C4Q34636336-026391C3-3602-464F-8B23-733D8BEFAA87Q34990433-EE6FACF4-D932-4F31-8DD9-B6035AC807D6Q35615776-D9593459-DD06-4C75-97D8-26E331C053F7Q35948050-4CB06543-77B7-453F-A97F-F45786288B33Q36178667-A4C3BB99-89B0-46CF-ADD7-63E6EA6BCD96Q36694859-E6AFB55B-8C2A-48D4-9E9B-CB533D4734BDQ36696255-161DB5C1-A5F0-4D15-890C-48FFB6F37E3BQ38750535-B1E3ED75-C290-44CE-AB78-8FD1E4A8348EQ42242337-B7E87647-A5F0-4AD9-A385-337809A6DD69
P2860
Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Expression levels of thymidine ...... n various human tumor tissues.
@ast
Expression levels of thymidine ...... n various human tumor tissues.
@en
type
label
Expression levels of thymidine ...... n various human tumor tissues.
@ast
Expression levels of thymidine ...... n various human tumor tissues.
@en
prefLabel
Expression levels of thymidine ...... n various human tumor tissues.
@ast
Expression levels of thymidine ...... n various human tumor tissues.
@en
P2093
P1476
Expression levels of thymidine ...... n various human tumor tissues.
@en
P2093
H Kinoshita
H Makuuchi
K Hirakawa-YS Chung
K Mizutani
P577
2000-07-01T00:00:00Z